IMMU-30. UTILIZING A NOVEL MASS CYTOMETRY-BASED IMMUNOMONITORING PLATFORM FOR THE CHARACTERIZATION OF VACCINE-REACTIVE, EPITOPE-SPECIFIC CD8(+) T-CELLS IN HLA-A*0201(+) PATIENTS WITH K27M(+) DIFFUSE MIDLINE GLIOMAS

Lignende værker

• IMMU-18. TARGETING H3.3 K27M MUTATION AS A SHARED NEOANTIGEN IN HLA-A*0201+ PATIENTS WITH DIFFUSE MIDLINE GLIOMAS – DEVELOPMENT OF A NOVEL MASS CYTOMETRY-BASED MONITORING OF VACCINE-REACTIVE, EPITOPE-SPECIFIC CD8+ T CELL RESPONSES
  af: Taitt, Jared, et al.
  Udgivet: (2019)
• IMMU-23. A NOVEL MASS CYTOMETRY-BASED MULTI-PARAMETER CHARACTERIZATION OF NEOANTIGEN-REACTIVE CD8+ T-CELLS IN PATIENTS PARTICIPATING IN PNOC007 H3.3K27M PEPTIDE VACCINE CLINICAL TRIAL
  af: Taitt, Jared, et al.
  Udgivet: (2020)
• IMMU-31. PNOC007: H3.3K27M SPECIFIC PEPTIDE VACCINE COMBINED WITH POLY-ICLC FOR THE TREATMENT OF NEWLY DIAGNOSED HLA-A2+ H3.3K27M DIFFUSE MIDLINE GLIOMAS (DMG)
  af: Mueller, Sabine, et al.
  Udgivet: (2020)
• PDCT-17 (LTBK-11). PNOC007: H3.3K27M SPECIFIC PEPTIDE VACCINE COMBINED WITH POLY-ICLC FOR THE TREATMENT OF NEWLY DIAGNOSED HLA-A2(+) H3.3K27M MIDLINE GLIOMAS
  af: Mueller, Sabine, et al.
  Udgivet: (2019)
• Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma
  af: Mueller, Sabine, et al.
  Udgivet: (2020)